Literature DB >> 11391276

Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units.

B H Stover1, S T Shulman, D F Bratcher, M T Brady, G L Levine, W R Jarvis.   

Abstract

BACKGROUND: Few data are available on nosocomial infections (NIs) in US children's hospitals' neonatal or pediatric intensive care units. The Pediatric Prevention Network (PPN) was established to improve characterization of NIs in pediatric patients and to develop and test interventions to decrease NI.
METHODS: Fifty participating children's hospitals were surveyed in 1998 to determine NI surveillance methods used and neonatal intensive care unit (NICU) and pediatric intensive care unit (PICU) 1997 NI rates. Data were collected on standardized forms and entered and analyzed by using SPSS for Windows.
RESULTS: Forty-three (86%) children's hospitals returned a completed questionnaire. All reported conducting NICU and PICU NI surveillance (range, 2-12; median, 12 months). Nineteen children's hospitals provided NICU NI rate data in one or more formats suitable for comparison. Denominators used for NICU NI rate calculations varied: 17 reported overall NI by patient-days; 19 reported bloodstream infection (BSI) by central venous catheter (CVC)-days, and 8 reported BSI by patient-days. Sixteen (16) children's hospitals reported NICU BSI data stratified by CVC-days and birth-weight cohort, and ventilator-associated pneumonia (VAP) by birth weight cohort was reported by 12. Twenty-four children's hospitals reported PICU NI rate data in one or more formats suitable for comparison. Denominators used for PICU NI rate calculations also varied: 20 reported overall NI rates by patient-days; 23 reported BSI rates by CVC-days, and 10 reported BSI rates by patient-days; 24 reported VAP by ventilator-days; and 15 reported urinary tract infections (UTIs) by urinary catheter-days. Median overall NI rates per 1000 patient days were 8.9 in NICUs and 13.9 in PICUs. Median NICU NI device-associated rates by birth weight (>2500 g, 1501-2500 g, 1001-1500 g, and </=1000 g) were BSI 4.4, 4.7, 8.9, and 12.6, and VAP 0.9, 1.1, 4.9, and 3.5, respectively. Median PICU NI rates per 1000 device days were 6.5 for BSI; 3.7 for VAP; and 5.4 for UTI.
CONCLUSIONS: The number of months that NICU or PICU NI surveillance was conducted varied among hospitals. Reported NICU and PICU NI rates varied by hospital; some reported overall NI rates, and others focused on one or more particular sites of infection (eg, BSI or pneumonia). Many did not provide NICU device-associated rates stratified by birth-weight group. Denominators used to calculate device-associated infection rates also varied, with hospitals reporting either patient-days or device-days. These findings suggest the need to determine reasons for variations and to identify optimal NI surveillance methods at children's hospitals so that valid interhospital NI rate comparisons can be made.

Entities:  

Mesh:

Year:  2001        PMID: 11391276     DOI: 10.1067/mic.2001.115407

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  23 in total

Review 1.  Healthcare-associated infection prevention in pediatric intensive care units: a review.

Authors:  N Joram; L de Saint Blanquat; D Stamm; E Launay; C Gras-Le Guen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-01       Impact factor: 3.267

2.  Presence of Invasive Devices and Risks of Healthcare-Associated Infections and Sepsis.

Authors:  Erin E Bennett; John VanBuren; Richard Holubkov; Susan L Bratton
Journal:  J Pediatr Intensive Care       Date:  2018-05-23

3.  The impact of statistical choices on neonatal intensive care unit quality ratings based on nosocomial infection rates.

Authors:  Henry C Lee; Alyna T Chien; Naomi S Bardach; Ted Clay; Jeffrey B Gould; R Adams Dudley
Journal:  Arch Pediatr Adolesc Med       Date:  2011-05

4.  Occurrence of endemic plasmids causing beta-lactam resistance in Enterobacteriaceae in children's university hospital in Munich.

Authors:  S Benczeová; D Adam; M Vrábelová; D Michálková-Papajová; M Kettner
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

5.  Population pharmacokinetics of cefepime in the neonate.

Authors:  Edmund Capparelli; Christine Hochwald; Maynard Rasmussen; Amy Parham; John Bradley; Fernando Moya
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 6.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

7.  Ventilator-Associated Pneumonia: Incidence, Risk Factors and Outcome in Paediatric Intensive Care Units at Cairo University Hospital.

Authors:  Yasmine S Galal; Meray Rene L Youssef; Sally K Ibrahiem
Journal:  J Clin Diagn Res       Date:  2016-06-01

Review 8.  Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients.

Authors:  Elizabeth Foglia; Mary Dawn Meier; Alexis Elward
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

9.  Ventilator associated pneumonia in critically-ill neonates admitted to neonatal intensive care unit, zagazig university hospitals.

Authors:  Mohamed A Badr; Yasser F Ali; Ehab A M Albanna; Mohamed R Beshir; Gahda E Amr
Journal:  Iran J Pediatr       Date:  2011-12       Impact factor: 0.364

10.  Nosocomial Infections among Pediatric Patients with Neoplastic Diseases.

Authors:  Peninnah Oberdorfer; Natthida Pongwilairat; Charles H Washington
Journal:  Int J Pediatr       Date:  2009-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.